Fecal Calprotectin Test Market revenue to hit USD 350 Million by 2035, says Research Nester
23 août 2023 07h30 HE
|
Research Nester
New York, Aug. 23, 2023 (GLOBE NEWSWIRE) -- The global fecal calprotectin test market size is predicted to grow at a CAGR of over ~12% from 2023 to 2035. The market is projected to garner a revenue...
Globus Medical Announces Launch of the MARVEL™ Growing Rod System, the company’s first product designed specifically for early onset scoliosis
31 juil. 2023 08h30 HE
|
Globus Medical
AUDUBON, Pa., July 31, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the commercial launch of the MARVEL™ Growing Rod...
Catalyst Pharmaceuticals Acquires Exclusive North American License For Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals
19 juil. 2023 06h00 HE
|
Catalyst Pharmaceuticals, Inc.
Vamorolone is a Promising Best-In-Class Dissociative Anti-Inflammatory Steroid Treatment for Duchenne Muscular Dystrophy Synergistic Novel Asset Leverages Catalyst's Expertise and Bolsters...
Ensemble pour l'espoir : Bunzl récolte des fonds records pour un traitement pédiatrique révolutionnaire des tumeurs cérébrales
13 juil. 2023 14h25 HE
|
Bunzl Canada Inc
BURLINGTON, Ontario, 13 juill. 2023 (GLOBE NEWSWIRE) -- Bunzl Canada est fier d'avoir organisé la 23e édition annuelle du tournoi de golf Ripple of Hope en soutien au Centre de recherche sur les...
Swinging for Hope – Bunzl Raises Record Funds for Revolutionary Pediatric Brain Tumour Treatment
13 juil. 2023 14h25 HE
|
Bunzl Canada Inc
BURLINGTON, Ontario, July 13, 2023 (GLOBE NEWSWIRE) -- Bunzl Canada is proud to have hosted its 23rd annual Ripple of Hope golf tournament in support of the Arthur & Sonia Labatt Brain Tumour...
Cardiometabolic Health Congress (CMHC) Launches Focused Digital Education Hubs
13 juil. 2023 11h00 HE
|
Cardiometabolic Health Congress
Boca Raton, FL, July 13, 2023 (GLOBE NEWSWIRE) -- The digital education from worldwide cardiometabolic event leader CMHC has undergone a reorganization. A vast collection of webinars, CME...
Catalyst Pharmaceuticals to License North American Rights to Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals
20 juin 2023 06h00 HE
|
Catalyst Pharmaceuticals, Inc.
Vamorolone is Currently Under Review with the FDA (PDUFA Date of October 26, 2023) for the Treatment of Duchenne Muscular Dystrophy, a Rare Neuromuscular Disease FDA has Granted Fast Track and Orphan...
Pediatric Catheters Market to Grow at 8.1% CAGR, Aiming for USD 12.6 Billion by 2032 - Market.us Report
26 mai 2023 03h47 HE
|
Market.Us
New York, May 26, 2023 (GLOBE NEWSWIRE) -- According to Market.us, the Pediatric Catheters Market size is projected to surpass around US$ 12.6 billion by 2032, and it is poised to reach a CAGR of...
Novan to Host Analyst and Investor Event: A Discussion of Molluscum’s Unmet Need with Pediatric Dermatologist Jeffrey Sugarman, MD, PhD
20 avr. 2023 09h00 HE
|
Novan, Inc.
DURHAM, N.C., April 20, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will host an Analyst and Investor Event: A Discussion of Molluscum’s...
Catalyst Pharmaceuticals Announces Third-Party Abstracts on FYCOMPA® (Perampanel) to be Presented at the Upcoming American Academy of Neurology 2023 Annual Meeting
20 avr. 2023 08h03 HE
|
Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., April 20, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on...